Anemia最新文献

筛选
英文 中文
A Retrospective Study Using Mentzer Index for Prevalence of Iron Deficiency Anemia among Infants Visiting Maternal Centers at the Age of One Year 使用Mentzer指数对1岁到产妇中心就诊的婴儿缺铁性贫血患病率进行回顾性研究
IF 2.9
Anemia Pub Date : 2022-03-27 DOI: 10.1155/2022/7236317
J. Amer
{"title":"A Retrospective Study Using Mentzer Index for Prevalence of Iron Deficiency Anemia among Infants Visiting Maternal Centers at the Age of One Year","authors":"J. Amer","doi":"10.1155/2022/7236317","DOIUrl":"https://doi.org/10.1155/2022/7236317","url":null,"abstract":"Anemia, defined as a hemoglobin level two standard deviations below the mean for age, is prevalent in infants and children worldwide. Characterizing anemia as microcytic and normocytic depends on the mean corpuscular volume (MCV), which is an important parameter in differentiating many types of anemia. Microcytic anemia due to iron deficiency is the most common type of anemia in children. In this study, we aimed to assess the Mentzer index used by the Ministry of Health (MOH) in Palestine as a useful tool in differentiating between iron deficiency anemia (IDA) and thalassemia. We assessed for the prevalence of IDA among infants at the age of one year visiting the mother centers from seven West Bank provinces in Palestine. Medical records and hematology laboratory data of 3262 infants were retrospectively analyzed from the years of 2018 to 2020. The Mentzer index applied to all population by dividing mean corpuscular volume (MCV, in fL) by the red blood cell count (RBC, in millions per microliter). A corrected Mentzer index was further calculated among anemic infants to include only microcytic (MCV with less than 72 fl) and hypochromic (mean corpuscular hemoglobin concentration (MCHC) with less than 32 g/L) indices. Mentzer index calculations for the whole population showed that 29.1% were anemic (hemoglobin (HGB) less than 11 g/dl): 21.1% had mild anemia, 7.6% had moderate anemia, while 0.2% had severe anemia. The corrected Mentzer index calculations showed a prevalence of 5.9% and 3.2% among IDA and thalassemia infants, respectively. Severity of anemia was correlated with low body weight and infants born through cesarean mother birth with no interference with gender influence. CBC indices of RBC count, HGB, MCV, and mean corpuscular hemoglobin (MCH) showed a significant difference (p values < 0.05) between IDA and thalassemia infants' populations following the corrected Mentzer index. With the corrected Mentzer index, we introduced a new CBC index among infants at the age of 1 year in Palestine. These lab references could aid in differentiating IDA and thalassemia among the population and improve initial diagnosis screenings. The Mentzer index calculation for the whole population did not necessarily include cases of IDA, and therefore, it is recommended to comprise microcytic and hypochromic anemia indices prior to performing the Mentzer index.","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43076694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Donor Blood Procurement, Safety, and Clinical Utilization: A Study of Blood Transfusion Services in a Tertiary Care Hospital in Nigeria 献血者血液的获取、安全性和临床利用:尼日利亚一家三级护理医院输血服务的研究
IF 2.9
Anemia Pub Date : 2022-03-17 DOI: 10.1155/2022/2622291
O. Nnachi, C. Uzor, C. Umeokonkwo, E. Onwe, A. Okoye, R. Ewah, F. O. Nwani
{"title":"Donor Blood Procurement, Safety, and Clinical Utilization: A Study of Blood Transfusion Services in a Tertiary Care Hospital in Nigeria","authors":"O. Nnachi, C. Uzor, C. Umeokonkwo, E. Onwe, A. Okoye, R. Ewah, F. O. Nwani","doi":"10.1155/2022/2622291","DOIUrl":"https://doi.org/10.1155/2022/2622291","url":null,"abstract":"Background Donated blood is an essential component of the management of many diseases, and hospital-based blood banks in Nigeria are saddled with the responsibility of provision of safe blood and coordination of its appropriate utilization for patient care. Objective This study reviewed the extent to which the hospital blood transfusion service ensures adequate safe blood supply and utilization. Materials/Methods. This was a retrospective study of 2 years record of the blood bank service of Alex Ekwueme Federal University Teaching. Methods of donor blood procurement, transfusion transmissible infection status, the pattern of blood, and blood component usage across the hospital's clinical departments were evaluated. Statistical analysis was conducted using IBM SPSS, and data were presented as percentages. Fisher's tests were used to test significance, and p value <0.05 is significant. Results The highest proportion of donors was male family replacement donors aged 26–35 years (3634 (39.68%)) while total voluntary donors were 315 (2.65%). Hepatitis B had the highest seroprevalence 267 (2.22%) among blood-borne diseases screened. National Blood Transfusion Service (NBTS) supplied only 3 (0.03%) of total blood units used. The accident and emergency department had the highest proportion of persons who utilized whole blood; 4568 (99.96%). Conclusion The hospital blood bank relies heavily on family replacement donors with little or no assistance from the National Blood Transfusion Service. Family replacement donors have the highest risk of TTIs, and hepatitis B infection has the highest prevalence. The high cost of blood component therapy increases the need for whole blood.","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2022-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48107760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review. 阐明d -二聚体水平与COVID-19严重程度的相关性:一项范围综述
IF 2.9
Anemia Pub Date : 2022-03-08 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9104209
Wesam Ahmed Nasif, Abeer Shaker El-Moursy Ali, Mohammed Hasan Mukhtar, Aali Marzouq H Alhuzali, Yahya Ahmed Yahya Alnashri, Ziyad Ishaq Ahmed Gadah, Eyyad Adeeb A Edrees, Hussam Abdulaziz Mabruk Albarakati, Hussam Saud Muhji Aloufi
{"title":"Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review.","authors":"Wesam Ahmed Nasif,&nbsp;Abeer Shaker El-Moursy Ali,&nbsp;Mohammed Hasan Mukhtar,&nbsp;Aali Marzouq H Alhuzali,&nbsp;Yahya Ahmed Yahya Alnashri,&nbsp;Ziyad Ishaq Ahmed Gadah,&nbsp;Eyyad Adeeb A Edrees,&nbsp;Hussam Abdulaziz Mabruk Albarakati,&nbsp;Hussam Saud Muhji Aloufi","doi":"10.1155/2022/9104209","DOIUrl":"https://doi.org/10.1155/2022/9104209","url":null,"abstract":"<p><strong>Aims: </strong>The review explores the findings of previous studies to elucidate the association between levels of D-dimer and COVID-19 severity and prognosis. In addition, we assessed the efficiency of anticoagulant therapies in reducing COVID-19 severity and improving the prognosis of the patients.</p><p><strong>Materials and methods: </strong>A comprehensive literature review was conducted using MEDLINE/PubMed databases, Scopus, and Web of Science with the help of keywords \"COVID-19,\" \"D-Dimer,\" \"Thrombosis,\" \"Fibrin network,\" \"Anticoagulant therapy,\" \"Inflammation,\" and \"disease severity.\" Based on all these articles and clinical experience, a scoping review was constructed and the full texts of the articles that were retrieved were accessed.</p><p><strong>Results: </strong>A D-dimer is a complex protein molecule that is formed during plasmin-mediated degradation of the fibrin network. Thus, it serves as a marker of thrombotic activity. On the other hand, in addition to severe respiratory distress and reduction in pulmonary gas exchange, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also triggers prothrombotic changes in the infected individuals. The levels of D-dimer have been postulated to be positively associated with the degree of disease severity among COVID-19 patients.</p><p><strong>Conclusions: </strong>It has been postulated that D-dimer could potentially be used as a biomarker to predict the prognosis and outcome of COVID-19 patients at the time of admission to hospitals and facilitate more personalized and efficient clinical management that could significantly reduce the mortality rate of such patients and allow more rapid recovery.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40306330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Pediatric Sickle Cell Disease in Sudan: Complications and Management. 苏丹儿童镰状细胞病:并发症和管理。
IF 2.9
Anemia Pub Date : 2022-02-14 eCollection Date: 2022-01-01 DOI: 10.1155/2022/3058012
Meysaa Talha, Bashier Osman, Safa Abdalla, Hind Mirghani, Iman Abdoon
{"title":"Pediatric Sickle Cell Disease in Sudan: Complications and Management.","authors":"Meysaa Talha,&nbsp;Bashier Osman,&nbsp;Safa Abdalla,&nbsp;Hind Mirghani,&nbsp;Iman Abdoon","doi":"10.1155/2022/3058012","DOIUrl":"https://doi.org/10.1155/2022/3058012","url":null,"abstract":"<p><strong>Background: </strong>Sickle cell disease (SCD) is a life-threatening genetic disorder due to the formation of sickle hemoglobin molecule (HbS) that polymerizes in hypoxic conditions leading to SCD-related complications. Different approaches have been used in the management of SCD including symptomatic management, supportive management, and preventive management.</p><p><strong>Objectives: </strong>To assess the management of SCD in pediatric patients in Gaafar Ibnauf Referral Hospital in Khartoum locality, Sudan.</p><p><strong>Method: </strong>A descriptive, retrospective, hospital-based study was conducted in Gaafar Ibnauf Hospital using a data collection sheet. The study included all medical files of pediatric patients with SCD attending the hospital during the period from the first of April 2018 to the first of July 2018. The data were analyzed using descriptive statistics and the chi-square test. <i>P</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Out of 207 pediatric patients, 53.1% were females (mean age of 7.5 ± 3.1 years), with a 1.1 : 1 female:male ratio and low socioeconomic status. Only 4.3% of participants had health insurance. The Messeryia tribe in western Sudan had the highest prevalence of the disease among the Sudanese tribes (11.1%). Vaso-occlusive crisis (33.3%), infections (13.5%), and neurological complications (10.6%) were the most frequent complications reported during routine visits. After initiation of management, only 3.4% of pediatric patients had hemolytic crises, and 1.4% of the anemic patients had splenomegaly. 100% of patients received folic acid, 73.9% used hydroxyurea, and 69.6% underwent blood transfusion for the management of SCD. Prophylactic penicillin was prescribed for 15% of patients, and 41.1% were immunized with pneumococcal vaccine (PPSV23). Most patients had been scheduled for planned follow-up visits every 3-6 months (93.2%). Hydroxyurea and blood transfusion significantly reduced fever and vaso-occlusive crisis.</p><p><strong>Conclusion: </strong>The SCD treatment protocol in Gaafar Ibnauf Children's Hospital, involving preventive and symptomatic therapy, is consistent with the internationally implemented protocols for SCD management. However, immunization and prophylactic penicillin approaches are deficient.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2022-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39809966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Neonatal Screening for Sickle Cell Disease in Congo. 刚果新生儿镰状细胞病筛查。
IF 2.2
Anemia Pub Date : 2022-02-03 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9970315
Alexis Elira Dokekias, Lethso Thibaut Ocko Gokaba, Josué Simo Louokdom, Lydie Ngolet Ocini, Firmine Olivia Galiba Atipo Tsiba, Coreillia Irène Ondzotto Ibatta, Quentin Ngoma Kouandzi, Serge Talomg Tamekue, Jayne Chelsea Bango, Jade Vanessa Nziengui Mboumba, Simon Charles Kobawila
{"title":"Neonatal Screening for Sickle Cell Disease in Congo.","authors":"Alexis Elira Dokekias, Lethso Thibaut Ocko Gokaba, Josué Simo Louokdom, Lydie Ngolet Ocini, Firmine Olivia Galiba Atipo Tsiba, Coreillia Irène Ondzotto Ibatta, Quentin Ngoma Kouandzi, Serge Talomg Tamekue, Jayne Chelsea Bango, Jade Vanessa Nziengui Mboumba, Simon Charles Kobawila","doi":"10.1155/2022/9970315","DOIUrl":"10.1155/2022/9970315","url":null,"abstract":"<p><strong>Introduction: </strong>Sickle cell disease is an autosomal recessive inherited disorder due to the mutation of a gene coding for the globin beta chain. The aim of this study is to update the epidemiological data on hemoglobinoses, in particular sickle cell disease in newborns in Congo.</p><p><strong>Materials and methods: </strong>This was a descriptive cross-sectional study, conducted from October 1, 2019, to March 31, 2020, throughout the Congolese national territory. It involved all full-term newborns, without distinction of nationality, aged 5 days or less, and whose parents consented to participate in the study. The blood samples, taken at the heel and collected on Whatman blotting paper, were analyzed using the HPLC Variant NBS machine.</p><p><strong>Results: </strong>In 2897 newborns (NN) screened, hemoglobin abnormalities were found in 603 NN (20.81%). The mean age of these newborns was 1 day (extremes 0 and 5 days). The male-to-female ratio was 1.03. Abnormal hemoglobins were mainly Hb S (<i>n</i> = 597 (97.71%)); Hb C (<i>n</i> = 5 (0.82%)); and variants (<i>n</i> = 7 (1.15%)). The national prevalence of major sickle cell (MSC) syndromes and sickle cell trait was 1.35% and 19.43%, respectively. The prevalence ranged from 1.77% to 2.56% for MSS in four departments and from 20.5% to 25.8% for the sickle cell trait in six other departments.</p><p><strong>Conclusion: </strong>Data on homozygous sickle cell disease remain consistent with previous studies. However, further studies should clarify the molecular anomalies of the variants observed in our samples.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism. 网织红细胞血红蛋白当量:评估甲状腺功能减退患者缺铁的诊断性能。
IF 2.9
Anemia Pub Date : 2021-11-12 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9071057
Wardah Aslam, Maryam Habib, Saeeda Aziz, Madiha Habib
{"title":"Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism.","authors":"Wardah Aslam,&nbsp;Maryam Habib,&nbsp;Saeeda Aziz,&nbsp;Madiha Habib","doi":"10.1155/2021/9071057","DOIUrl":"https://doi.org/10.1155/2021/9071057","url":null,"abstract":"Introduction Iron deficiency affects approximately 30% of the world population and is frequently encountered in hypothyroid patients. Early recognition and prompt treatment of iron deficiency in hypothyroid patients lead to a favorable outcome. The aim of this study is to prove the usefulness of reticulocyte hemoglobin equivalent (Ret-He) as a reliable and effective tool in diagnosis of iron deficiency in hypothyroid patients. Materials and Methods 154 patients with hypothyroidism were included in the study. They were divided into 4 groups. Group 1 included 66 hypothyroid patients without iron deficiency. They were taken as controls. Group 2 included 66 hypothyroid patients with iron deficiency anemia (IDA). Group 3 included 12 hypothyroid patients with iron deficiency but without anemia (ID). Group 4 included 10 hypothyroid patients which had concomitant iron deficiency with anemia of chronic disorder (ACDC). Ret-He was measured by analyzing blood samples on System XN 350. Thyroid profile, serum ferritin, and biochemical data were measured by an automated analyzer. Statistical analysis was performed by using SPSS 23. Results Ret-He was significantly lower with (p < 0.001) in group 2 (hypothyroid patients with IDA), group 3 (hypothyroid patients with ID), and in group 4 (hypothyroid patients with ACDC) as compared to controls in group 1 (hypothyroid patients without iron deficiency). After ROC analysis area under the curve (AUC) of Ret-He for hypothyroid patients with IDA was 0.96 at cutoff 28.5 pg with sensitivity of 93% and specificity of 90%. AUC of Ret-He in the hypothyroid group with ACDC was 0.99 at cutoff 30.8 pg with sensitivity of 90% and specificity of 90%. AUC of Ret-He in hypothyroid patients with ID was 0.97 at cutoff 31.7 pg with sensitivity of 91% and specificity of 70%. Conclusion Ret-He is a reliable, rapid, and cost-effective tool for diagnosing iron deficiency in hypothyroid patients.","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39643940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review. 镰状细胞病的口腔面部表现和牙科治疗:范围综述。
IF 2.9
Anemia Pub Date : 2021-10-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5556708
Mayank Kakkar, Kristen Holderle, Megha Sheth, Szilvia Arany, Leslie Schiff, Adela Planerova
{"title":"Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review.","authors":"Mayank Kakkar,&nbsp;Kristen Holderle,&nbsp;Megha Sheth,&nbsp;Szilvia Arany,&nbsp;Leslie Schiff,&nbsp;Adela Planerova","doi":"10.1155/2021/5556708","DOIUrl":"https://doi.org/10.1155/2021/5556708","url":null,"abstract":"<p><strong>Aims: </strong>Sickle cell disease (SCD) is an upcoming global health problem with rapid progress in therapy especially since 2017. However, systematic reviews found no clinical trials on the dental treatment of sickle cell disease (SCD). This article aims to outline the oral features of the sickle disease and discuss oral management strategies that can serve as guidelines for dental professionals. <i>Material and Methods</i>. A comprehensive literature review was conducted using PubMed, Google Scholar, and Web of Science. The search strategies were developed to cover publications from January 2010 to March 2020. With the help of keywords, multiple abstracts were identified. These abstracts were further reviewed, which included the information about the SCD manifestation, particularly about the oral health features. Based on all these articles and clinical experience, a narrative review was constructed, which summarizes all the aspects of the oral manifestation in people with SCD.</p><p><strong>Results: </strong>The results of this study demonstrate that there is distinct evidence available, indicating the developmental enamel defect leading to hypoplasia and increasing susceptibility to dental caries. Another important result of this review found that people with SCD have a vaso-occlusive crisis in the microcirculation in the dental pulp leading to symptomatic and asymptomatic pulpal necrosis without any signs of odontogenic pathology in an apparently healthy tooth. The study also found that early detection, intervention, and prevention are crucial for improving oral health care, and involving a multidisciplinary approach plays an important role in managing people with SCD.</p><p><strong>Conclusion: </strong>Patients with sickle cell disease have chronic overall health problems. The hematological disorder becomes their main concern and impaired oral health becomes secondary, increasing the risk for dental caries at the most. This paper broadly describes the oral manifestations of SCD, additionally; this paper also provides recommendations for better dental management of patients with SCD. Patients with SCD are often misjudged and, due to lack of knowledge and guidelines, dental providers are not able to provide adequate care. This paper attempts to highlight the essential measures to provide better dental care.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39579824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia. 成人输血依赖型β地中海贫血症患者铁负荷与 CD4 之间的相关性。
IF 2.9
Anemia Pub Date : 2021-06-17 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5549503
Tubagus Djumhana Atmakusuma, Ralph Girson, Sukamto Koesnoe
{"title":"Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia.","authors":"Tubagus Djumhana Atmakusuma, Ralph Girson, Sukamto Koesnoe","doi":"10.1155/2021/5549503","DOIUrl":"10.1155/2021/5549503","url":null,"abstract":"<p><strong>Background: </strong>Thalassemia is a hereditary disease, and severe anemia is the main phenotype of major thalassemia. Furthermore, the most important method in the management of this disease is red blood cell transfusion. Regular transfusions administered 1 or 2 times every month improve prognosis and survival. However, there is higher risk of infections and iron overload, especially in transfusion-dependent thalassemia (TDT). Infections are the second leading cause of death in adult TDT, after heart failure. Higher risk of infection is also influenced by multiple blood transfusions which causes alteration in immune response due to alloimmunization, transfusion-related infections, and iron overload. Meanwhile, iron overload in TDT alters both innate and specific immune responses. Furthermore, previous studies have shown the correlation between ferritin with CD4, but this has not been carried out in Indonesia. Therefore, this study aims to determine the correlations between iron overload (serum ferritin and transferrin saturation) and specific immune cells (CD4).</p><p><strong>Methods: </strong>This is a cross-sectional study, and a total number of 64 subjects were examined consecutively. Chest X-ray and blood sera were obtained. The total number of subjects was 64. The seromarkers HBsAg, anti-HCV, and anti-HIV were tested using the ELISA method. Serum ferritin and transferrin saturation was tested using ECLIA, and lymphocyte subsets were analyzed using flowcytometry. Meanwhile, the correlation between variables was determined using Spearman's test.</p><p><strong>Results: </strong>The results showed that 4.9% subjects were HBsAg positive, 10.7% were anti-HCV positive, and none were anti-HIV positive. There were 4 subjects with lung tuberculosis based on the 41 chest X-ray. Meanwhile, there was a weak negative and insignificant correlation between serum ferritin with CD4 (<i>p</i>=0.75; <i>r</i> = -0.04) and a weak positive and insignificant correlation between transferrin saturation with CD4 (<i>p</i>=0.133; <i>r</i> <i>=</i> 0.19).</p><p><strong>Conclusion: </strong>There were no correlations between iron overload (ferritin) and cellular immunity (CD4) in adult transfusion-dependent thalassemia.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2021-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39166361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties. 人获得性再生障碍性贫血患者骨髓间充质干细胞不受造血区室影响并保持干性和免疫特性
IF 2.9
Anemia Pub Date : 2021-04-29 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6678067
Vandana Sharma, Sonali Rawat, Suchi Gupta, Sweta Tamta, Rinkey Sharma, Tulika Seth, Sujata Mohanty
{"title":"Human Acquired Aplastic Anemia Patients' Bone-Marrow-Derived Mesenchymal Stem Cells Are Not Influenced by Hematopoietic Compartment and Maintain Stemness and Immune Properties.","authors":"Vandana Sharma,&nbsp;Sonali Rawat,&nbsp;Suchi Gupta,&nbsp;Sweta Tamta,&nbsp;Rinkey Sharma,&nbsp;Tulika Seth,&nbsp;Sujata Mohanty","doi":"10.1155/2021/6678067","DOIUrl":"https://doi.org/10.1155/2021/6678067","url":null,"abstract":"<p><strong>Methods: </strong>In the current study, we investigated the morphological differences, proliferation capacity, population doubling time (PDT), surface marker profiling, trilineage differentiation potential, and immunosuppressive ability of BM Mesenchymal Stem Cells (BM-MSCs) from untreated aAA patients and in the same number of age- and gender-matched controls.</p><p><strong>Results: </strong>We observed similar morphology, proliferation capacity, phenotype, trilineage differentiation potential, and immunomodulatory properties of BM-MSCs in aAA patients and control subjects.</p><p><strong>Conclusion: </strong>Our results confirm that the basic and immunosuppressive properties of BM-MSCs from aAA patients do not differ from normal BM-MSCs. Our data suggest that BM-MSCs from aAA patients might not be involved in disease pathogenesis. However, owing to a smaller number of samples, it is not conclusive, and future studies with more exhaustive investigation at transcriptome level are warranted.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38998738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients. 输血依赖性印尼地中海贫血患者的铁超载。
IF 2.9
Anemia Pub Date : 2021-04-15 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5581831
Pandji Irani Fianza, Anita Rahmawati, Sri Hudaya Widihastha, Shofura Afifah, Mohammad Ghozali, Andre Indrajaya, Dilli Marayuzan Akbar Pratama, Dimmy Prasetya, Teddy Arnold Sihite, Mas Rizky A A Syamsunarno, Djatnika Setiabudi, Suthat Fucharoen, Ramdan Panigoro
{"title":"Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients.","authors":"Pandji Irani Fianza,&nbsp;Anita Rahmawati,&nbsp;Sri Hudaya Widihastha,&nbsp;Shofura Afifah,&nbsp;Mohammad Ghozali,&nbsp;Andre Indrajaya,&nbsp;Dilli Marayuzan Akbar Pratama,&nbsp;Dimmy Prasetya,&nbsp;Teddy Arnold Sihite,&nbsp;Mas Rizky A A Syamsunarno,&nbsp;Djatnika Setiabudi,&nbsp;Suthat Fucharoen,&nbsp;Ramdan Panigoro","doi":"10.1155/2021/5581831","DOIUrl":"https://doi.org/10.1155/2021/5581831","url":null,"abstract":"<p><p>Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe anemia and thus regular blood transfusion is necessary. However, there have been known transfusions-related consequences, including iron overload and multi-organ damage. The aims of this study were to evaluate liver and cardiac function in youth and adult transfusion-dependent Indonesian thalassemic patients and to assess its correlation with serum ferritin levels, as well as T2 <sup><i>∗</i></sup> magnetic resonance imaging (MRI). Transfusion-dependent thalassemic (TDT) outpatients (<i>n</i> = 66; mean age, 21.5 ± 7.2 years) were carried out for the complete assessment consisting of blood test including liver enzyme and serum ferritin, followed by electrocardiography (ECG) and echocardiography. Subjects were also divided by serum ferritin levels into three groups: < 2500 ng/mL, 2500-5000 ng/mL, and >5000 ng/mL. Additionally, subgroup analysis in patients with T2<sup>∗</sup> MRI assessment was conducted. In terms of age of first blood transfusion, subjects with ferritin >5000 ng/mL were the youngest among others. The alanine aminotransferase (ALT) levels in group with serum ferritin >5000 ng/mL were significantly higher than those of the group with serum ferritin <2500 ng/mL. Additionally, youth and adult TDT patients whose serum ferritin >5000 ng/mL had significantly lower tricuspid annular plane systolic excursion (TAPSE) when compared with those who had serum ferritin <2500 ng/mL. Similarly, TAPSE in patients with moderate cardiac siderosis based on cardiac T2<sup>∗</sup> MRI was significantly lower than those without cardiac siderosis. There was significant, but only moderate correlation between serum ferritin and cardiac T2<sup>∗</sup> MRI. Based on these findings, it is important to routinely monitor iron accumulation-related complications, including liver and cardiac damage in youth and adult TDT patients.</p>","PeriodicalId":46055,"journal":{"name":"Anemia","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2021-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38963998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信